Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 11:46AM CST
LEJU: 10.83 (-0.01), GEOS: 24.93 (-0.45), LXRX: 0.85 (-0.05), OTIV: 1.68 (-0.06), GME: 32.30 (-1.61), ARUN: 19.49 (-0.03), NBS: 3.58 (+0.31), PHMD: 1.37 (-0.10), AMDA: 0.69 (-0.01), CANF: 3.49 (+0.03), MOLG: 2.90 (-0.05), WAIR: 13.53 (+0.05), EDAP: 2.15 (+0.02), FWM: 2.83 (-0.12), GERN: 3.24 (+0.01), OCRX: 6.10 (-0.05), NGVC: 25.93 (-0.38), SFUN: 7.73 (+0.06), EJ: 8.28 (-0.10), BGI: 1.40 (-0.08)
EDAP gets a boost after earnings report
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 11:27AM CST
EDAP: 2.15 (+0.02)
EDAP TMS' (EDAP) CEO Marc Oczachowski on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 20, 9:56AM CST
EDAP: 2.15 (+0.02)
EDAP TMS S.A. (EDAP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 20, 7:25AM CST
EDAP: 2.15 (+0.02)
EDAP ups revenues 22% in Q3
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 7:17AM CST
EDAP: 2.15 (+0.02)
EDAP TMS S.A. EPS of $0.33
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 6:40AM CST
EDAP: 2.15 (+0.02)
EDAP Reports Continued Strong Growth in Third Quarter 2014
GlobeNewswire - Thu Nov 20, 6:30AM CST
Highlights
EDAP: 2.15 (+0.02)
EDAP's Ablatherm-HIFU PMA not approvable
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 9:52AM CST
EDAP: 2.15 (+0.02)
EDAP Receives FDA Guidance on PMA for Ablatherm-HIFU
GlobeNewswire - Thu Nov 06, 7:43AM CST
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today received a letter from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on its current PMA application for Ablatherm Integrated Imaging Device. The FDA letter stated that while EDAP's Ablatherm-HIFU PMA is not approvable in its current form, it provides specific guidance and recommendations as to a path forward. This guidance was provided in accordance with the requirements of 21 CFR 814.44(f), which states that the FDA, where practical, must identify measures necessary to make the PMA approvable.
EDAP: 2.15 (+0.02)
Edap reports November 20
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 11:22AM CST
EDAP: 2.15 (+0.02)
EDAP to Report Third Quarter 2014 Results on November 20, 2014
GlobeNewswire - Tue Nov 04, 7:30AM CST
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the third quarter ended September 30, 2014 on Thursday, November 20, 2014, during pre-market hours.
EDAP: 2.15 (+0.02)
EDAP Announces Sale of Focal One(R) HIFU Device to Nantes-Atlantis Urology Clinic in France
GlobeNewswire - Tue Oct 21, 7:39AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the sale of a Focal One system to Nantes-Atlantis urology clinic, the top-ranked private prostate cancer clinic in France, and the country's only private clinic exclusively dedicated to urology.
EDAP: 2.15 (+0.02)
EDAP Presents Results of Its Ablatherm-HIFU FDA Study at 4th International Symposium of the Focused Ultrasound Foundation, Washington D.C.
GlobeNewswire - Mon Oct 13, 8:45AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that data on clinical outcomes of its Ablatherm-HIFU FDA study (the "Enlight Trial"
EDAP: 2.15 (+0.02)
EDAP Announces Sale of Focal One(R) HIFU Device to Mannheim University Hospital, Germany
GlobeNewswire - Tue Oct 07, 8:20AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first successful treatments performed at Germany's Mannheim University Hospital ("UMM"
EDAP: 2.15 (+0.02)
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action against EDAP TMS S.A. and Its Board of Directors and a Lead Plaintiff Deadline of October 3, 2014
Business Wire - Mon Sep 29, 5:33PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased EDAP TMS S.A. ("EDAP" or the "Company"
EDAP: 2.15 (+0.02)
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in EDAP TMS SA (EDAP) to Contact the Firm
GlobeNewswire - Mon Sep 29, 10:29AM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in EDAP TMS SA ("EDAP" or the "Company"
EDAP: 2.15 (+0.02)
EQUITY ALERT: Rosen Law Firm Reminds EDAP TMS S.A. Investors of Important October 3, 2014 Class Action Deadline -- EDAP
GlobeNewswire - Sat Sep 27, 11:01PM CDT
The Rosen Law Firm reminds purchasers of the securities of EDAP TMS S.A. (Nasdaq:EDAP) during the period from February 1, 2013 through July 30, 2014, of the important October 3, 2014 lead plaintiff deadline in the class action.
EDAP: 2.15 (+0.02)
EDAP's Ablatherm(R)-HIFU Technology Highlighted at the World Congress of Endourology, Taiwan
GlobeNewswire - Mon Sep 22, 7:31AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that the growing interest in and acceptance of its Ablatherm(R)-HIFU technology was once again highlighted as a valuable treatment alternative for prostate cancer patients in a presentation at the World Congress of Endourology (WCE) in Taipei, Taiwan from September 3-7, 2014.
EDAP: 2.15 (+0.02)
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of EDAP TMS S.A. Of Upcoming Deadline
Business Wire - Thu Sep 18, 3:57PM CDT
Rigrodsky & Long, P.A.:
EDAP: 2.15 (+0.02)